Comparison of Dydrogesterone and Micronized Progesterone Treatments in the Treatment of Threatened Miscarriage.

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05542797

Enrollment

140

Registered

2022-09-15

Start date

2022-10-31

Completion date

2024-11-30

Last updated

2022-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Miscarriage Threatening

Brief summary

In this study, we aimed to compare the effects of two drugs used for the threated miscarriage on the miscarriage rate.

Detailed description

About 140 pregnant women who applied to our clinic due to the threated miscarriage in the first trimester will be randomly given micronized progesterone to half and dydrogesterone to the other half. After the treatment, the miscarriage rates in the groups will be compared.

Interventions

DRUGDuphastone

dydrogesterone hormone

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 30 Years

Healthy volunteers

Inclusion criteria

* pregnant women with threated miscarriage in the first trimester.

Exclusion criteria

* \- pregnant women with abortus incipiens.

Design outcomes

Primary

Measure	Time frame	Description
Miscarriage rate	One year	Effects of two drugs to be used on live birth rate in pregnant women with threated miscarriage

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026